Risk of Breast Cancer Recurrence Reduced With Letrozole, International Study Finds
Novel Antifungal Agent Highly Active Against Esophageal Candidiasis
Piperacillin/Tazobactam Valuable Empiric Therapy For Febrile Neutropenia
Cholesterol-Lowering Drugs May Prevent Breast Cancer
Acceptance Of Sentinel Node Biopsy Is Growing, Study Finds
NCCN Updates Breast Cancer Guidelines for Patients
Lung Cancer Clinical Trials Cost-Effective Alternative
Letters From Ovarian Cancer Survivors Shed Light On Their Psychological Distress
New Drug Reduces Nausea and Vomiting
Clinical Trials Approved By NCI
Trending Stories
- Dana-Farber/Harvard Cancer Center awarded $12M NIH SPORE grant to advance breast cancer research
- Anthony Letai sworn in as 18th NCI director
- U.S. government shuts down
Impact on NCI uncertain as administration threatens more RIFs - Former NCI official’s nonprofit seeks to tell the stories of cancer patients
Patient Action for Cancer Research aims to show impact of federal research - Sakaguchi, Ramsdell, Rudensky win Crafoord Prize for discoveries in immune regulation
- The evolution of cellular immunotherapy: From transplant to CAR T cells